Workflow
senba(300701)
icon
Search documents
森霸传感:生产的热释电红外传感器、光敏电阻、光敏传感器产品可以应用到消费电子领域
Zheng Quan Ri Bao· 2026-02-25 11:41
(文章来源:证券日报) 证券日报网讯 2月25日,森霸传感在互动平台回答投资者提问时表示,公司生产的热释电红外传感器、 光敏电阻、光敏传感器产品可以应用到消费电子领域。 ...
森霸传感(300701) - 关于使用暂时闲置自有资金进行现金管理的进展公告
2026-02-24 08:30
证券代码:300701 证券简称:森霸传感 公告编号:2026-007 森霸传感科技股份有限公司 关于使用暂时闲置自有资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 森霸传感科技股份有限公司(以下简称"公司")为提高资金使用效率,合理 利用暂时闲置资金,经第五届董事会第八次会议和第五届监事会第六次会议,审 议通过了《关于继续使用暂时闲置自有资金进行现金管理的议案》,同意公司及 控股子公司继续使用额度不超过人民币 2 亿元的暂时闲置自有资金进行现金管 理,购买安全性较高、流动性好的中低风险理财产品,在最高限额内的额度可循 环使用,使用期限不超过 12 个月。具体内容详见公司刊载于巨潮资讯网 (www.cninfo.com.cn)的相关公告。 近日,公司购买理财产品的相关事项有了新的进展,具体情况如下: 一、公司本次使用暂时闲置自有资金购买理财产品基本情况 1、事项一 | 签约方名称 | 中国光大银行股份有限公司 | | | | | --- | --- | --- | --- | --- | | 产品名称 | 定期存单 | | | | ...
森霸传感:公司的产品主要应用于LED照明、安防等领域,目前在AI上尚无应用
Mei Ri Jing Ji Xin Wen· 2026-02-12 14:30
Core Viewpoint - The company, Senba Sensor (300701.SZ), currently does not have applications in AI but is closely monitoring the demand for AI in the sensor industry and is focused on technological research and development to enhance its capabilities and product offerings [2]. Group 1: Company Overview - Senba Sensor's products are primarily used in various fields including LED lighting, security, digital electronics, intelligent transportation, smart home, and wearable devices [2]. - The company emphasizes continuous improvement in technology and innovation to expand its product categories and provide comprehensive technical products and services to customers [2]. Group 2: AI Application - As of now, the company has no applications in AI technology [2]. - The company is committed to keeping a close watch on the impact of AI applications on sensor demand [2].
森霸传感股东减持与业绩预告引关注
Jing Ji Guan Cha Wang· 2026-02-11 06:20
股价异动原因 经济观察网森霸传感(300701)(300701.SZ)在2026年第一季度有以下值得关注的事件,基于近期公告 和市场动态。 公司已发布2025年业绩预告,预计全年归母净利润6.53亿至7.33亿元,同比增长41%至59%。投资者可 关注后续正式年报的披露时间。 公司状况 实际控制人一致行动人"康腾8号"私募基金已于2026年1月6日完成减持并不再持股,导致实际控制人阵 营持股比例降至32.91%,后续需关注其他股东动向。 以上内容基于公开资料整理,不构成投资建议。 实际控制人一致行动人单颖计划自2026年3月3日至6月2日,通过集中竞价方式减持不超过1,732,563股 (占总股本的0.6128%),按2026年1月30日收盘价13.04元/股计算,预计减持金额约2,259万元。大股东盈 贝投资(持股16.12%)计划自2026年3月11日至6月10日,通过集中竞价和大宗交易方式减持不超过848万 股(占总股本的3%),其中集中竞价部分不超过282.74万股。 业绩经营情况 ...
森霸传感:大股东盈贝投资拟减持不超过3%公司股份
Zhong Zheng Wang· 2026-02-10 06:05
Core Viewpoint - The major shareholder of Senba Sensor, Ganzhou Yingbei Investment Development Co., Ltd., plans to reduce its stake in the company by up to 8.48 million shares, representing no more than 3% of the total share capital, between March 11, 2026, and June 10, 2026 [1] Group 1 - As of the announcement date, Yingbei Investment holds 45.57 million shares of Senba Sensor, accounting for 16.12% of the total share capital [1] - The reduction will involve 10 related personnel of Senba Sensor, with Chairman Dan Senlin planning the largest reduction of up to 2.20 million shares, which is 0.7767% of the total share capital [1] - Vice Chairman Zhang Hui and Research Institute Director Zheng Guoen plan to reduce their stakes by 0.6234% and 0.5707%, respectively, while other board members and directors will reduce their stakes by less than 0.5% [1] Group 2 - On January 30, Senba Sensor announced that the actual controller and Vice General Manager Dan Senlin's associated person, Dan Ying, intends to reduce her stake by up to 1.73 million shares [1] - Public information indicates that Dan Senlin and Dan Ying are father and daughter [1]
2月10日重要公告一览
Xi Niu Cai Jing· 2026-02-10 02:35
Group 1 - Fangda Carbon plans to acquire 100% equity of Tianjin Tongda Huanyu Logistics Co., Ltd. for 319 million yuan [1] - Xiamen Tungsten intends to acquire 39% equity of Jiujiang Dadi Mining Development Co., Ltd. and has signed an intention agreement with a transferor [6] - Wenkai Co. has won a bid for a landscape project worth 50.8162 million yuan [7] Group 2 - Changchun High-tech's subsidiary Jin Sai Pharmaceutical received approval for a clinical trial application for GenSci136, a treatment for IgA nephropathy [3] - China National Pharmaceutical has received drug registration certificates for fumaric acid volnoral tablets, used for treating reflux esophagitis [12] - Zhenhua Group plans to issue convertible bonds not exceeding 1.2 billion yuan [26] Group 3 - CSG Holding's stock may undergo a control change due to share pledge judicial transfer [30] - Ningbo Yunsheng plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [19] - Keda Guochuang's controlling shareholder intends to transfer 5% of the company's shares through an agreement [28] Group 4 - A number of companies, including Finer Pharma, Yixing Guoyuan Investment, and others, have announced plans to reduce their shareholdings by various percentages [2][4][9][11][15][16][20][21][22][23][25][29] - Highweida plans to repurchase shares worth 30 to 35 million yuan [17] - ST Zhongzhu is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [24] Group 5 - A number of companies, including Jiekang Equipment and others, have faced legal issues or penalties [27][40] - Aclaris Therapeutics has clarified that reports regarding its robotic products entering mass production were misinterpreted [41]
增减持公告汇总丨这家公司股东拟1亿元—1.5亿元增持股份
Di Yi Cai Jing· 2026-02-09 13:46
Group 1 - The controlling shareholder of Bowei Alloy plans to increase its stake in the company by 100 million to 150 million yuan [1] - The actual controller and directors of Congsheng Co. intend to reduce their holdings by no more than 5% of the company's shares [1] - Yinbei Investment of Senba Sensor plans to reduce its stake by no more than 3% of the company's shares [1] Group 2 - The controlling shareholder and its concerted parties of Liansheng Chemical plan to reduce their holdings by no more than 3% of the company's shares [1] - A shareholder of ST Zhongzhu intends to reduce its stake by no more than 3% of the company's shares [1] - Shareholders of Youde Precision (rights protection) plan to collectively reduce their holdings by no more than 3% of the company's shares [1] Group 3 - Shareholder Finer of Xuantai Pharmaceutical plans to reduce its stake by no more than 2% of the company's shares [1] - A shareholder of Far East Co. intends to reduce its holdings by no more than 1.5% of the company's shares [1] - A shareholder of Zhongzhou Special Materials plans to reduce its stake by no more than 1.4% of the company's shares [1] Group 4 - Qianhai Jin控 plans to reduce its stake in GCL-Poly Energy by no more than 1.01% of the company's shares [1] - The controlling shareholder of Keda Technology intends to reduce its holdings by no more than 1% of the company's shares [1] - Yulong Venture Capital plans to reduce its stake in Haiguo Co. by no more than 0.9965% of the company's shares [1] Group 5 - Shareholders of Lian Technology plan to collectively reduce their holdings by no more than 0.96% of the company's shares [1] - The controlling shareholder of Teda Co. intends to reduce its holdings by no more than 29.38 million shares [1] - The actual controller of Perfect World reduced its stake by 1.247 million shares during a period of abnormal stock fluctuations [1] Group 6 - A shareholder of Tengya Precision plans to reduce its stake by no more than 3.8 million shares [1]
森霸传感(300701.SZ):盈贝投资拟减持不超过3%股份
Ge Long Hui A P P· 2026-02-09 13:39
Core Viewpoint - The major shareholder, Yingbei Investment, plans to reduce its stake in Senba Sensing (300701.SZ) by up to 8.482 million shares, which represents no more than 3% of the company's total share capital [1] Group 1: Shareholder Reduction Plan - The reduction will occur within three months starting from March 11, 2026, and will be executed through centralized bidding and block trading methods [1] - Specific planned reductions by key executives include: - Chairman Shan Senlin: up to 2,195,879 shares - Vice Chairman Zhang Hui: up to 1,762,505 shares - Research Institute Director Zheng Guoen: up to 1,613,577 shares - Director Sun Yuzhen: up to 543,246 shares - Other executives also have specified share reductions totaling various amounts [1]
今日晚间重要公告抢先看——金徽股份:拟2.1亿元收购福圣矿业100%股权;盟固利:拟9.29亿元投建年产3万吨锂离子电池正极材料项目
Jin Rong Jie· 2026-02-09 13:25
Group 1 - Jinwei Co., Ltd. plans to acquire 100% equity of Fusheng Mining for 210 million yuan, which will become a wholly-owned subsidiary and included in the consolidated financial statements [2] - Mengguli intends to invest 929 million yuan to build a project with an annual production capacity of 30,000 tons of lithium-ion battery cathode materials, expected to produce 5,000 tons of high-voltage cobalt acid lithium, 10,000 tons of NCA materials, and 15,000 tons of ultra-high nickel ternary materials [2] - Xiamen Tungsten plans to acquire 39% equity of Jiujiang Dadi Mining, which will help increase mineral resource reserves and improve raw material self-sufficiency [3] Group 2 - Andavil's subsidiary received EASA certification for its aviation kitchen plug-in products, marking compliance with European aviation safety standards [2] - CIMC Vehicles disclosed that the US ITC made a preliminary ruling on anti-subsidy and anti-dumping investigations regarding Van-Type Trailers, indicating potential damage to the US domestic industry [4] - Source Technology plans to invest approximately 1.251 billion yuan to build a second phase project for the R&D and production of optoelectronic communication semiconductor chips and devices [9] Group 3 - Zhongmin Energy intends to acquire 51% equity of Mintou Pumped Storage for 864 million yuan, with the transaction price based on asset evaluation [10] - Ningbo Yunsheng plans to publicly issue H-shares and apply for listing on the Hong Kong Stock Exchange [11] - Wenkai Co., Ltd. won a bid for a landscape project worth 50.8162 million yuan [12] Group 4 - China Merchants Shekou achieved a signed sales amount of 7.674 billion yuan in January 2026 [16] - AVIC Optoelectronics reported a net profit of 2.124 billion yuan for 2025, a year-on-year decrease of 36.69% [17] - Tiankang Bio reported a sales revenue of 392 million yuan from pig sales in January 2026, with a month-on-month increase of 6.23% [18] Group 5 - Poly Developments reported a signed amount of 15.617 billion yuan in January 2026, a year-on-year decrease of 13.31% [19] - Chengtou Holdings reported a net profit of 290 million yuan for 2025, a year-on-year increase of 19.67% [20] - Qianjin Pharmaceutical reported a net profit of 288 million yuan for 2025, a year-on-year increase of 24.74% [21]